A multigenic approach to evaluating prostate cancer risk in a systematic replication study

Fang Chi Hsu, Sara Lindström, Jielin Sun, Fredrik Wiklund, Shyh Huei Chen, Hans Olov Adami, Aubrey R. Turner, Wennuan Liu, Katarina Bälter, Jin Woo Kim, Pär Stattin, Bao li Chang, William B. Isaacs, Jianfeng Xu, Henrik Grönberg, S. Lilly Zheng

Research output: Contribution to journalArticlepeer-review

Abstract

Although it is well known that multiple genes may influence prostate cancer risk, most current efforts at identifying prostate cancer risk variants rely on single-gene approaches. In previous work using mostly single-gene approaches, we observed significant associations (P < 0.05) for 6 of 46 polymorphisms in five genes in a Swedish prostate cancer case-control study population. We now report on the higher-order gene-gene interactions among those 46 genetic variants and the combined effect of the six polymorphisms with significant main effects for association with prostate cancer risk in 795 controls and 1,461 cases. Classification and regression tree analysis was used to evaluate higher-order gene-gene interactions. No interactions were confirmed by the result from logistic regressions. For the combined analysis, we tested the hypothesis that individuals carrying multiple copies of risk variants are at increased risk for prostate cancer. Individuals carrying more than eight copies of any risk variant were almost twofold more likely to get prostate cancer (OR = 1.99, P = 0.0014). A significant trend relationship was observed (P < 0.0001). In the present study, additive effects but not multiplicative effects among these six polymorphisms with significant main effects were observed.

Original languageEnglish (US)
Pages (from-to)94-98
Number of pages5
JournalCancer Genetics and Cytogenetics
Volume183
Issue number2
DOIs
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'A multigenic approach to evaluating prostate cancer risk in a systematic replication study'. Together they form a unique fingerprint.

Cite this